These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3084442)

  • 41. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
    Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ
    N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of MRSA strains isolated from cases of mupirocin ointment treatment in which eradication was successful and in which eradication failed.
    Ogura M; Yano H; Sato M; Nakamura A; Wakimoto Y; Ohkusu K; Ezaki T
    J Infect Chemother; 2013 Apr; 19(2):196-201. PubMed ID: 22806444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overview of the role of mupirocin.
    Lamb YJ
    J Hosp Infect; 1991 Sep; 19 Suppl B():27-30. PubMed ID: 1684188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts.
    Manian FA
    Clin Infect Dis; 2003 Jan; 36(2):e26-8. PubMed ID: 12522764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of mupirocin ointment in the treatment of secondarily infected dermatoses.
    Breneman DL
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-Level Mupirocin Resistance in Staphylococcus spp. among Health Care Workers in a Tertiary Care Hospital.
    Kavitha E; Srikumar R
    Pharmacology; 2019; 103(5-6):320-323. PubMed ID: 30889613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis.
    Luber H; Amornsiripanitch S; Lucky AW
    Arch Dermatol; 1988 Jun; 124(6):853-4. PubMed ID: 3132108
    [No Abstract]   [Full Text] [Related]  

  • 49. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
    Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage.
    Perl TM; Golub JE
    Ann Pharmacother; 1998 Jan; 32(1):S7-16. PubMed ID: 9475834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
    Fawley WN; Parnell P; Hall J; Wilcox MH
    J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.
    Kalmeijer MD; Coertjens H; van Nieuwland-Bollen PM; Bogaers-Hofman D; de Baere GA; Stuurman A; van Belkum A; Kluytmans JA
    Clin Infect Dis; 2002 Aug; 35(4):353-8. PubMed ID: 12145715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
    Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
    Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review.
    Boelaert JR
    J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
    Dupeyron C; Campillo B; Richardet JP; Soussy CJ
    J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reclassification of Staphylococcus aureus nasal carriage types.
    van Belkum A; Verkaik NJ; de Vogel CP; Boelens HA; Verveer J; Nouwen JL; Verbrugh HA; Wertheim HF
    J Infect Dis; 2009 Jun; 199(12):1820-6. PubMed ID: 19419332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mupirocin ointment indications.
    Hudson I
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):452. PubMed ID: 2121821
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.
    Pérez-Fontán M; Rosales M; Rodríguez-Carmona A; Moncalián J; Fernández-Rivera C; Cao M; Valdés F
    Adv Perit Dial; 1992; 8():242-5. PubMed ID: 1361797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
    Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
    Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.